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Measuring multiple neurochemicals and related metabolites
in blood and brain of the rhesus monkey by using dual
microdialysis sampling and capillary hydrophilic
interaction chromatography–mass spectrometry
Juan Li & Veronika von Pföstl & Daniel Zaldivar &
Xiaozhe Zhang & Nikos Logothetis & Alexander Rauch
Abstract In vivo measurement of multiple functionally
related neurochemicals and metabolites (NMs) is highly
interesting but remains challenging in the field of basic
neuroscience and clinical research. We present here an
analytical method for determining five functionally and
metabolically related polar substances, including acetylcho-
line (quaternary ammonium), lactate and pyruvate (organic
acids), as well as glutamine and glutamate (amino acids).
These NMs are acquired from samples of the brain and the
blood of non-human primates in parallel by dual micro-
dialysis, and subsequently analyzed by a direct capillary
hydrophilic interaction chromatography (HILIC)–mass
spectrometry (MS) based method. To obtain high sensitivity
in electrospray ionization (ESI)–MS, lactate and pyruvate
were detected in negative ionization mode whereas the
other NMs were detected in positive ionization mode
during each HILIC-MS run. The method was validated for
linearity, the limits of detection and quantification, preci-
sion, accuracy, stability and matrix effect. The detection
limit of acetylcholine, lactate, pyruvate, glutamine, and
glutamate was 150 pM, 3 μM, 2 μM, 5 nM, and 50 nM,
respectively. This allowed us to quantitatively and simulta-
neously measure the concentrations of all the substances
from the acquired dialysates. The concentration ratios of
both lactate/pyruvate and glutamine/glutamate were found
to be higher in the brain compared to blood (p<0.05). The
reliable and simultaneous quantification of these five NMs
from brain and blood samples allows us to investigate their
relative distribution in the brain and blood, and most
importantly paves the way for future non-invasive studies
of the functional and metabolic relation of these substances
to each other.
Keywords Neurochemicals . HILIC-MS .Microdialysis .
Rhesus monkey . Brain . Blood
Introduction
The physiological function of neurons and the correct
information processing within the brain depend critically on
neuroactive molecules and metabolites (NMs). These NMs
consisting of neurotransmitters like glutamate or neuro-
modulators like acetylcholine can be detected by appropri-
ate techniques in the extracellular fluid of the brain. The
concentrations of these NMs are tightly controlled and
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stable within narrow boundaries. Many disorders of the
central nervous system (CNS) such as Parkinson’s disease
[1], Alzheimer’s disease [2], and schizophrenia [3], are
correlated with or even caused by changes in the concen-
trations of such substances. NMs can be sampled from the
extracellular brain fluid (EBF) which allows us to investi-
gate their dynamic reflecting changes in neuronal activity.
The EBF forms a complex, dynamic environment embed-
ding all neural elements and serves as medium for the cell-
to-cell communication and metabolite transport. Many of
these NMs also exist in the blood system, but their
concentrations are commonly different from those in the
brain because of the differential permeability of the blood
brain barrier (BBB) and of differences in absorption
mechanisms, synthesis, and metabolism. Simultaneous and
quantitative monitoring of these NMs from the brain and
the blood system will therefore allow us to assess their
relation between the brain and the blood system.
In the present study, we focused on a selection of NMs
functionally and metabolically related and developed a
direct and sensitive analytical method to monitor acetyl-
choline, lactate, pyruvate, glutamine, and glutamate in
parallel from the brain and the blood. All these five
substances are derivates from glucose and the citrate cycles
[4, 5]. Additionally, acetylcholine is able to modulate
glutamatergic release and can interact with the brain energy
metabolism [6–8]. To do so, we used microdialysis to
collect samples from EBF and blood of anesthetized non-
human-primates in parallel. This will allow us to investigate
changes in their relation caused by functional and metabolic
challenges or by pathologies in the future. However, their
chemical and physical properties are different which makes
it difficult to separate and detect these NMs together. To the
best of our knowledge, there is currently no report
describing the simultaneous determination of all five
aforementioned substances by a single analysis. Indeed, so
far, most analytical methods developed were only focusing
on the determination of one or two of such targeted
substances. For example, electrochemical detection (ECD)
is commonly used to monitor these compounds [9–11], but
an additional enzyme reactor is needed to generate
electrochemically detectable hydrogen peroxide for acetyl-
choline detection [12], so it is difficult to monitor all these
substances in a single analytical run using ECD as detector.
Compared to the classical ECD, mass spectrometry (MS) is
able to detect diverse NMs with high sensitivity and
selectivity. Recent analytical advances have been made by
using MS detection coupled with ion-pair reversed-phase
liquid chromatography (RPLC) or ion exchange chroma-
tography (IEC) as separation tools. For instance, acetylcho-
line has been analyzed by strong cation exchange (SCX)-
MS [13] or ion-pair RPLC-MS [14, 15]. Pyruvate was
analyzed by weak anion exchange (WAX)-MS [16], while
lactate and pyruvate together were detected by RPLC-ESI/
MS (electro spray ionization, ESI), but a time-consuming
derivatization process with 3-nitrophenyl-hydrazine was
needed [17]. Glutamine and glutamate were determined
by ion-pair RPLC-MS using an ion-pairing regent which
might cause ESI suppression [18].
In contrast to ion-pair RPLC or IEC-based analytical
approaches, hydrophilic interaction liquid chromatography
(HILIC)–MS is an alternative technique that allows
separating and determining multiple polar analytes irre-
spective of being a base or an organic acid [19, 20]. It
already has proved its merits in determining peptides,
proteins and small polar molecular compounds in complex
matrices [21–24]. Recent reports demonstrated that HILIC-
MS is well suited to determine polar neurotransmitters in
EBF offering high sensitivity combined with time-saving
procedures for sample preparation [23, 25].
In this study, we report the successful combination of
capillary HILIC-ESI/MS with dual microdialysis sampling
for simultaneous measurement of five NMs together in
brain and blood dialysates of non-human primates. First,
our approach allows us to compare the relation of these
NMs to each other under different physiological and
pathological states of the brain. Second, the simultaneous
sampling from the brain and the blood can be used to
extrapolate from blood measurements to brain concentra-
tions of these NMs. Relation changes of these NMs
detectable in the blood can serve as easy accessible
biomarkers reflecting physiological or pathological states
of the brain [26].
Experimental
Chemicals
HPLC-MS grade acetonitrile, formic acid, and ammonium
formate were purchased from Sigma-Aldrich (Munich,
Germany). [3-13C] lactate (as aqueous solution, 20% w/
w in H2O) (
13C-lactate), glutamine-L-2, 3, 3, 4, 4-d5
(glutamine-d5), and glutamic acid-L-2, 3, 3, 4, 4-d5
(glutamate-d5) were purchased from Cambridge Isotope
Laboratories (Andover, USA). Acetylcholine-N,N,N-tri-
methyl-d9 chloride (acetylcholine-d9) was bought from
Medical Isotopes, Inc (Pelham, USA). Acetylcholine
chloride, sodium lactate (lactate), sodium pyruvate, gluta-
mine, glutamate, [1-13C] sodium pyruvate (13C-pyruvate),
and the chemicals for preparing frits were all obtained from
Sigma-Aldrich. Pure water was produced by a TKA
superpure water system (Niederelbert, Germany). Artificial
cerebral spinal fluid (a-CSF) for standard solutions con-
sisted of 148 mM NaCl, 3.00 mM KCl, 0.80 mM MgCl2,
and 1.40 mM CaCl2, pH 7.3.
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Fabrication of capillary columns
The preparation of capillary columns was adopted and
modified from Zhang et al. [23]. To prevent the packing
material from spilling out of the column a frit was formed
at one end by in situ free radical polymerization modified
from Viklund et al. [27]. Compared to the frit formed by
sintered reaction, our frit can easily withstand long
exposure to high pressure (>3,000 psi) and minimize
extra-column band broadening. After the reaction, un-
reacted material and other soluble compounds were
removed from the pores by washing with ethanol followed
by purging with helium for 15 min. The column was
packed with acetone slurry (1.5 mL) containing 50 mg of
5 μm polyhydroxyethyl aspartamide particles (PolyLC,
USA) with the help of a helium pressure cell with a stirring
bar to maintain particle suspension running under a
pressure of 100 bars for 30 min. The packed column was
cut to 15 cm for use.
Preparation of calibration standards and internal standards
To increase the reproducibility of the quantitative analysis
of acetylcholine, lactate, pyruvate, glutamine, and gluta-
mate, acetylcholine-d9,
13C-lactate, 13C-pyruvate,
glutamine-d5, and glutamate-d5 were used as their respec-
tive internal standards (IS). Stock solutions of the analytes
were prepared in 30% acetonitrile containing 0.1% formic
acid and stored at 5 °C. To characterize the analytical
performance of capillary HILIC-MS methods for the
quantitative measurement of the analytes, the stock solution
was serially diluted using a solution containing a-CSF/
solution A (90% acetonitrile, 0.1% formic acid; 1:4, v/v).
The calibration solutions of acetylcholine ranged from 0.5–
250 nM and consisted of three levels (low, medium, and
high) of quality control (QC) samples with 2.5, 25, and
125 nM. For lactate and pyruvate, the calibration solutions
ranged from 10–5,000 μM, and QC samples were 50, 500,
and 2500 μM. For glutamine, the calibration solutions
ranged from 0.5–250 μM, and QC samples were 2.5, 25,
and 125 μM. For glutamate the calibration solutions ranged
from 0.25–125 μM, and QC samples were 1.25, 12.5, and
62.5 μM. Two IS stock solutions were prepared in water
containing 0.1% formic acid: one (IS1) is used for the
calibration curve preparation and the blood microdialysate
samples analysis, which contains 500 nM acetylcholine-d9,
10 mM 13C-lactate, 10 mM 13C-pyruvate, 500 μM
glutamine-d5, and 250 μM glutamate-d5; the other one
(IS2) is used for the monkey brain microdialysate samples
analysis containing 300 nM acetylcholine-d9, 6 mM
13C-
lactate, 6 mM 13C-pyruvate, 300 μM glutamine-d5, and
150 μM glutamate-d5. These internal standards were
diluted ten times (IS1) and six times (IS2) on the day of
the assay using a-CSF/solution A (90% acetonitrile, 0.1%
formic acid; 1:4, v/v). The calibration curve was con-
structed based on the response ratio of the peak area
(Panalyte/PIS) versus the nominal standard concentrations
by a least-squares regression using a weighting factor of 1/
concentration2.
Microdialysis sampling
Two male rhesus monkeys (Macaca mulatta) were used
with an age of 5 years weighing between 6 and 7 kg. The
experimental procedures were approved by the local
authorities (in German: “Regierungspraesidium Tuebin-
gen”) and were in agreement with guidelines of the
European Community (EUVD 86/609/EEC) for the care
and use of laboratory animals. During the experiment, the
monkeys were anesthetized with full monitoring of all vital
parameters. Before the experiment, the monkeys were
sedated with ketamine (15 mg/kg). Anesthesia was induced
with fentanyl (31 μg/kg), thiopental (5 mg/kg), and
succinyl chloride (3 mg/kg). Afterwards, the monkeys were
intubated and ventilated with a Servo Ventilator 900 C
(Siemens, Germany). The maintenance of anesthesia was
attained with remifentanyl (0.2–1 μg/kg/min) and mivacu-
rium chloride (4–7 mg/kg/h). A crystalloid solution
(Ionosteril, Fresenius Kabi, Germany) with 2.5% glucose
was infused at a rate of 10 ml/kg/h. During the experiment,
body temperature was kept between 38.5 and 39.5 °C,
SpO2 above 95% and end tidal CO2 at 35 mmHg.
The monkeys had a miniaturized PEEK chamber over
the primary visual cortex that gave access to the brain. The
probe was inserted through a small incision in the dura. The
probe for blood sampling was placed into a superficial leg
vein using an intravenous catheter.
For brain sampling, microdialysis probes CMA 12 with
2 mm PAES membrane of 0.5 mm outer diameter (o.d.) and
a 20 kDa cut-off (CMA Microdialysis AB, Sweden) were
used. The probe was flushed with a-CSF solution at a flow
rate of 2 μL/min for 15 min, and then conditioned at a flow
rate of 600 nL/min for 2 h before insertion into the cortex
of the monkey. For the blood sampling, a microdialysis
catheter CMA 64, 20 mm PAES membrane, 0.6 mm o.d.,
20 kDa cut-off (CMA Microdialysis AB, Sweden) was
flushed with saline containing fragmin 25 IU/mL (Pfizer
Pharma GmbH, Germany) at a flow rate of 2 μL/min for
2 h before insertion. The collections of microdialysis
samples were started 2 h after the insertion of the probes
for blood sampling as well as for brain sampling.
The dialysates were collected in parallel by two
refrigerated fraction collectors CMA 740 (CMA Micro-
dialysis AB, Sweden) at 6 °C for 1 h. The samples were
collected at an interval of 3 min for both brain and blood
sampling. We collected simultaneously five brain and five
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blood samples each time. The sampling experiments were
repeated two times from each animal. Before sampling, the
IS solution was added to the glass inserts used for sample
collection and then put into the refrigerated fraction
collectors. After the experiment, the brain microdialysate
samples were concentrated by a vacuum concentrator
(Eppendorf, Germany) under room temperature for 5 min
and reconstituted by solution B (60% acetonitrile, 0.1%
formic acid) for further analysis. The blood microdialysate
samples were directly diluted by solution C (80% acetoni-
trile, 0.1% formic acid) and then analyzed.
In vitro recovery of CMA 12 probes has been tested in
our lab, and it was 50.2–66.8% for all analytes with a
reliable stability not exceeding 3.6% standard errors. The
measured in vitro recovery of CMA 64 probes for all
analytes was 42.5–49.3% with good reliable stability not
exceeding 4.3% standard errors.
Capillary liquid chromatography and mass spectrometry
An Agilent capillary HPLC 1100 system coupled to a XCT
plus ion-trap mass spectrometer (Agilent, Waldbronn,
Germany) was used for analysis. Mobile phase A was an
aqueous solution containing 50 mM ammonium formate
and 1.0% formic acid (pH 2.87), and mobile phase B was
acetonitrile. The analysis was performed using a gradient
profile: 0.0–10.0 min, 85% B to 45% B, then 45% B was
kept for 5 min. The column was reconditioned using an
85% solution of B for 10 min before further injection. The
flow rate was 3.5 μL/min, and a sample of 0.3 μL was
injected in the column each time.
MS analysis was performed by switching between
positive and negative ion mode. Ion-trap tandem mass
spectrometry (MS/MS) experiments were applied to isolate
and fragment the precursor ions. The mass spectrometer
was operated in MRM mode (multiple-reaction-monitoring)
for the quantitative analysis. Five scans were averaged for
each spectrum with the scan range of m/z 50–2,000. MS
scans were split into three segments considering the
different MS behaviors of five compounds. In the first
segment (0.0–3.5 min) acetylcholine and acetylcholine-d9
were monitored under a positive mode with the capillary
voltage of 3,500 V, while lactate, 13C-lactate, pyruvate and
13C-pyruvate were monitored under a negative mode in the
second segment (3.5–8.6 min) with the capillary voltage of
2,541 V, and glutamine, glutamine-d5, glutamate, and
glutamate-d5 were monitored under a positive mode in the
third segment (8.6–15.0 min) with capillary voltage of
3200 V. The MS parameters of five analytes and their
corresponding internal standards are listed in Table 1.
Lactate and pyruvate did not generate significant and stable
product ions, so we could not use the product ions for
lactate and pyruvate in MRM conditions. We used ion
fragmentation amplitude of 0.5 V and ion fragmentation
cut-off of 58 which reduced the background noise keeping
the lactate and pyruvate unaffected. This procedure could
compensate for the lack of specificity which is achieved by
monitoring the transfer from the precursor ion to the
product ion. The MS settings such as capillary exit,
skimmer and lens voltages were optimized and tuned by
the data acquisition software during infusion of a standard
solution for each compound.
Results and discussion
HILIC-MS analytical method development
Highest intensities for all the analytes were achieved when
both the positive and the negative ionization mode of the
mass spectrometer were used in the ESI experiments.
Previous studies showed that chemicals can have different
ESI/MS responses because of their different physical and
chemical properties [28]. In our case, lactate and pyruvate,
which are organic acids, had much higher intensities in
negative ionization mode than in positive ionization mode.
The other analytes, acetylcholine, glutamine and glutamate
generated responses with high intensity only in positive
ionization mode. For our experiments, we thus used
positive ionization mode for detecting acetylcholine, gluta-
mine, and glutamate, while negative ionization mode for
lactate and pyruvate. In the analytical experiments, we
selected HILIC as the method to separate the five polar
analytes. Our initial tests showed that HILIC was able to
separate them simultaneously (data not shown). The elution
order was acetylcholine, lactate, pyruvate, glutamine, and
glutamate. Because both positive and negative ionization
mode were used for ESI/MS detection, the efficient
separation of lactate and pyruvate from the other analytes
has to be achieved to ensure that each analyte reliably
matches the time window of the appointed ionization mode.
To achieve optimal separation and intensity of the five
analytes on the HILIC-MS, we examined the influence of
pH value, water content and buffer concentration of the
mobile phase on the retention behavior and MS signal of
each analyte. Figure 1a shows that the pH value had clearly
stronger effects on lactate and glutamate compared to the
other three analytes when we varied the pH of mobile phase
A from 2.7–4.2 by adjusting formic acid proportions from
0.05–1.50%. In particular, the elution order of lactate and
pyruvate reversed when pH value ranged from 3.9–2.7.
This may be because lactate is ionized at higher pH values
compared to its pKa of 3.85. Figure 1d indicates that the
MS intensity of the five analytes was also affected by the
pH value. Their intensities were on average higher at lower
pH value; 1.0% formic acid (pH 2.9) was finally used for

ht
tp
://
do
c.
re
ro
.c
h
the following optimization warranting efficient separation
combined with high intensity.
The water content had strong influence on the chro-
matographic behaviors and MS signal intensities of all five
analytes. When the water content was decreased to 30% or
lower, lactate and pyruvate could be very well separated
from their neighboring peaks of acetylcholine and gluta-
mine in the chromatogram (Fig. 1b). Figure 1e illustrates
that the reduced water content (from 60–30%) could
enhance the MS intensity, which is the benefit of the
increased electrospray ionization efficiency in a high
organic phase. On the other hand, a MS signal decline
was observed when the water content ranged from 30% to
20%. This might result from the low solubility of the polar
compounds in the high organic phase mobile.
During the method development, we found that the salt
content in the buffer solution had a great impact on the peak
shapes and MS signal of the analytes (Fig. 1f), but less
effect on retention time (Fig. 1c). Sharp peak shapes and
high reproducible retention times were obtained for all
Table 1 MS parameters for five analytes and their internal standards
Compounds MRM transition Width Frag. cut-off (m/z) Frag. amplitude (V) ICC smart target (m/z) ICC accumulation time (ms)
Ach 146→87 1.0 62 1.38 200,000 200
Ach-d9 155→87 1.0 62 1.38 200,000 200
Lac 89→89 1.0 58 0.50 200,000 100
13C-Lac 90→90 1.0 58 0.50 200,000 100
Pyr 87→87 1.0 58 0.50 200,000 100
13C-Pyr 88→88 1.0 58 0.50 200,000 100
Gln 147→130 1.0 69 1.20 50,000 200
Gln-d5 152→135 1.0 69 1.20 50,000 200
Glu 148→130 1.0 60 0.98 50,000 200
Glu-d5 153→135 1.0 60 0.98 50,000 200
Fig. 1 Influences of mobile phase on retention behavior and MS
signal of the five analytes. a Effects of pH value on the retention time.
b Effects of water content on the retention time. The aqueous phase
containing 50 mM ammonium formate and 1.0% formic acid. c
Effects of buffer concentration on the retention time. Mobile phase A
containing 1.0% formic acid. d Effects of pH value on MS signal. e
Effects of water content on MS signal. f Effects of buffer
concentration on MS signal. An isocratic elution of mobile phase A:
mobile phase B (15:75, v/v) was used to test the influence of pH value
and buffer concentration. *Acetylcholine (Ach), Lactate (Lac),
Pyruvate (Pyr), Glutamine (Gln), Glutamate (Glu)
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analytes when the ammonium formate concentration was
increased from 10–50 mM. Therefore, a higher concentra-
tion of buffer solution was used for the elution, although
ion suppression could be observed at this level.
Taken together, the aqueous phase consisted of a buffer
solution containing 50 mM ammonium formate and 1.0%
formic acid using a gradient profile that started at 85%
acetonitrile for separation of the targeted analytes. This
optimized separation method ensured that each analyte was
matching the appointed time window of the chosen
ionization mode without any interferences. The typical
HILIC-ESI/MS chromatograms containing the five NMs
Fig. 2 Representative HILIC-ESI/MS chromatograms of five NMs under the optimized conditions a blood sample b brain sample. Both positive
and negative ion mode was adopted for the detection of five analytes during each run
Table 2 Validation results of the HILIC-ESI/MS method for the analysis of the five neurochemical analytes
Precision a
Compounds LOD LOQ Linear range r2 Accuracy (%) Intra-day Inter-day
RSD%, n=5 RSD%, n=3
ACh 150 pM 450 pM 0.5–250 nM 0.9989 82.6–109.0 11.6 12.8
Lac 3 μM 10 μM 10–5000 μM 0.9990 86.0–106.8 9.6 15.2
Pyr 2 μM 6 μM 10–5000 μM 0.9989 85.6–117.4 10.5 14.3
Gln 5 nM 15 nM 0.5–250 μM 0.9990 81.5–117.8 10.3 13.3
Glu 50 nM 150 nM 0.25–125 μM 0.9988 86.0–106.9 14.6 15.0
a Intra-day and Inter-day precisions were analyzed by one-way ANOVA analysis.
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(acetylcholine, lactate, pyruvate, glutamine, and glutamate)
are shown in Fig. 2.
Analytical performance of the capillary HILIC-ESI/MS
method
The capillary HILIC-ESI/MS method was validated for the
quantitative measurements of acetylcholine, lactate, pyru-
vate, glutamine, and glutamate concentrations from in vivo
dialysates. We characterized a series of parameters like the
limits of detection (LODs), limits of quantification (LOQs),
linearity, selectivity, accuracy, precision and stability by
analyzing different levels of standard mixtures of the target
NMs while using optimized MRM transitions and positive/
negative ionization modes. The validated results of the
analytical performance are listed in Table 2. The LODs of
lactate and pyruvate in negative mode were 3 and 2 μM,
respectively, whereas the LODs of acetylcholine, gluta-
mine, and glutamate in positive mode were 150 pM, 5 nM,
and 50 nM, respectively. Although the LODs of lactate and
pyruvate were much higher than those of the other three
analytes (acetylcholine, glutamine, and glutamate) we still
can measure them, because their basal concentrations in the
brain as well in the blood are much higher than the other
three. The matched MS/MS pattern between the endoge-
nous NMs and their standards allowed confirming the high
selectivity of the HILIC-MS method. Additionally, the
retention time of the endogenous NMs always matched well
with those of internal standards under different gradient
elution conditions, which also proved the high selectivity of
the method. The accuracy, precision and stability have been
tested by replicate analysis (five determinations per
concentration) of three different levels of QCs (see the
section “Preparation of calibration standards and internal
standards”). It is shown in Table 2 that the results of the
accuracy, intra- and inter-day precisions were all in good
agreement with the requirements of biological analysis [29,
30]. The stability test results indicated that the stock
solution was stable for 1 month at −20 °C with the RSD<
12.5%, and the QCs were stable for about 2 weeks in the
autosampler at 4 °C with the RSD<15.1%. Additionally,
the freeze (−20 °C) and thaw stability has also been tested
for these analytes. After two freeze-thaw cycles, the QCs
were analyzed on the third cycle, and the results showed a
good stability with the RSD<13.1%.
In addition, we adopted the post-extraction spike method
proposed by Matuszewski et al. [31] to evaluate the matrix
effect of the acquired in vivo samples in our study. To
reliably determine the endogenous concentration of the five
analytes we analyzed them according our developed
method and then checked the same brain and blood samples
by spiking with appropriate standard solutions. The spiked
concentration of acetylcholine, lactate, pyruvate, glutamine,
and glutamate was 8 nM, 150 μM, 10 μM, 40 μM, and
1 μM respectively for the brain samples, while 20 nM,
400 μM, 60 μM, 300 μM, and 30 μM for the blood
samples. The total concentrations of the five analytes in the
spiked samples and the endogenous concentrations in the non-
spiked samples were then determined and used to calculate the
recovery of each analyte. We used the following formula for
calculating the recovery: (measured value−endogenous val-
ue)/added value×100. The obtained recoveries for the five
analytes fell in the range of 93–112%.
Concentrations of acetylcholine, lactate, pyruvate,
glutamine, and glutamate in the brain and blood
microdialysates
We applied capillary HILIC-ESI/MS method together with
simultaneous blood and brain microdialysis sampling to
measure the concentrations of five NMs from two anesthe-
Table 3 Concentrations of acetylcholine, lactate, pyruvate, glutamine, and glutamate in the dialysates of brain and blood
Compounds Ach (nM) Lac (μM) Pyr (μM) Gln (μM) Glu (μM)
Brain 4.0±1.4 220.4±90.9 21.3±8.3 50.4±21.9 1.1±0.2
Blood 10.3±4.4 511.3±78.7 91.5±37.6 176.4±45.3 26.7±5.3
Anesthetized monkeys, resting status. Values are given as mean±standard error of the mean (S.E.M.); n=4.
Fig. 3 Comparison of lactate/pyruvate (Lac/Pyr) and glutamine/
glutamate (Gln/Glu) in primary visual cortex and the blood system
of rhesus monkey. Ratios of Lac/Pyr and Gln/Glu in monkey primary
visual cortex were significantly higher than the blood system (p<0.05)
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tized male rhesus monkeys. The microdialysis probe in the
brain was placed into the primary visual cortex (V1). The
concentrations of acetylcholine, lactate, pyruvate, gluta-
mine, and glutamate in dialysates from primary visual
cortex and blood are shown in Table 3. The values we
monitored were in good agreement with the Human
Metabolome Database Version 2.5 (www.hmdb.ca), and
the values reported in the literature [18, 23, 32–39].
Comparison of lactate/pyruvate and glutamine/glutamate
ratios in the brain and the blood
To further understand the distribution differences of NMs
across the BBB, respectively, between the brain and the
blood, we examined and compared the lactate/pyruvate and
glutamine/glutamate ratios between the brain and blood
dialysates. The results showed that the concentration ratio
of lactate/pyruvate and glutamine/glutamate was signifi-
cantly different between the brain and the blood. The values
of lactate/pyruvate and glutamine/glutamate were calculated
and are shown in Fig. 3. The mean lactate/pyruvate ratio in
the brain was 14.5, but only reached 9.0 in the blood
system. The mean ratio of glutamine/glutamate in the brain
was 53.4, significantly higher than the blood value of 7.9.
One-way ANOVA analysis confirmed the statistical signif-
icance of these findings (p<0.05).
The lactate/pyruvate ratio in the human brain is currently
considered a specific, sensitive marker that could potential-
ly indicate whether glucose and oxygen supply meet the
energy requirements of the brain tissue [40]. Such marker,
that hint upon the adequacy of energy and metabolite
supply are of great importance for the detection of onset of
neurodegenerative diseases [41]. In the human brain, a
lactate/pyruvate ratio above 40 indicates an “energy crisis”
[42]. Additionally it was shown that lactate can increase the
cerebral blood flow which correlates with an increase of the
lactate/pyruvate ratio in the plasma [36]. A decreased
interstitial glutamine/glutamate ratio has been observed in
acute and chronic brain damage such as traumatic brain
injury [43], hypoxia [44], and epilepsy [45]. Although such
findings are still preliminary for diagnosis, we consider the
simultaneous monitoring of blood and brain concentrations
of important NMs a necessary step in this direction to get a
clear understanding of their chemical relation across the
BBB. On the basis of this data, extrapolations from the
blood concentrations to brain concentrations of pathologi-
cally relevant NMs might be envisioned.
Conclusion
We developed a capillary HILIC-ESI/MS method for the
simultaneous determination of multiple chemicals including
acetylcholine, lactate, pyruvate, glutamine and glutamate
from the brain (EBF) and blood system of anesthetized
non-human primates. To achieve highest intensity of these
NMs, positive and negative ionization modes were used for
MS detection. The optimized chromatographic separation
allowed us to switch between the two detection modes and
to simultaneously measure these NMs in a single run. A
simple and fast sample treatment was carried out after
collection by microdialysis without any additional sample
purification or derivatization. We have successfully dem-
onstrated that our method can reliably quantify these NMs
in dialysates collected from the blood and the primary
visual cortex of non-human primates. Additionally we
found that the concentration ratio of lactate/pyruvate and
glutamine/glutamate was significantly different between the
brain and the blood, reflecting the active transports and
different metabolic processes between the blood and the
nervous system respectively across the BBB. Quantified
coupling parameters between the blood and the nervous
system of NMs are of outmost importance due to their
possible use in the diagnosis of pathological processes in
the brain. To further investigate the correlation of these
NMs between the brain and the blood systems, we will use
the developed analytical method to test the dynamic change
of these NMs across the BBB by pharmacologically
simulating dysfunctional states of the brain.
Acknowledgments This work was supported by the Max Planck
Society and BMBF Grant, Nr. 01EV0701. We thank Nadine Serr and
Ulrike Passlack-Memaj for assistance in chemical preparations. We
thank Mark Augath for assistance with the monkey anesthesia.
References
1. Calabresi P, Centonze D, Gubellini P, Marfia GA, Pisani A, Sancesario
G, Bernardi G (2000) Synaptic transmission in the striatum: from
plasticity to neurodegeneration. Prog Neurobiol 61:231–265
2. D’Aniello A, Lee JM, Petrucelli L, Di Fiore MM (1998) Regional
decreases of free D-aspartate levels in Alzheimer’s disease.
Neurosci Lett 250:131–134
3. Carlsson M, Carlsson A (1990) Interactions between glutamater-
gic and monoaminergic systems within the basal ganglia—
implications for schizophrenia and Parkinson’s disease. Trends
Neurosci 13:272–276
4. Gibson GE, Peterson C, Sansone J (1981) Neurotransmitter and
carbohydrate metabolism during aging and mild hypoxia. Neuro-
biol Aging 2:165–172
5. Hertz L, Peng L, Dienel GA (2006) Energy metabolism in
astrocytes: high rate of oxidative metabolism and spatiotemporal
dependence on glycolysis/glycogenolysis. J Cereb Blood Flow
Metab 27:219–249
6. Briand LA, Gritton H, Howe WM, Young DA, Sarter M (2007)
Modulators in concert for cognition: modulator interactions in the
prefrontal cortex. Prog Neurobiol 83:69–91
7. Andersson K, Arner P (1995) Cholinoceptor-mediated effects on
glycerol output from human adipose tissue using in situ micro-
dialysis. Br J Pharmacol 115:1155–1162

ht
tp
://
do
c.
re
ro
.c
h
8. Yang TT, Chang CK, Tsao CW, Hsu YM, Hsu CT, Cheng JT
(2009) Activation of muscarinic M-3 receptor may decrease
glucose uptake and lipolysis in adipose tissue of rats. Neurosci
Lett 451:57–59
9. Tsai TR, Cham TM, Chen KC, Chen CF, Tsai TH (1996)
Determination of acetylcholine by on-line microdialysis coupled
with pre-and post-microbore column enzyme reactors with
electrochemical detection. J Chromatogr B Biomed Sci Appl
678:151–155
10. Yao T, Yano T, Nanjyo Y, Nishino H (2003) Simultaneous
determination of glucose and L-lactate in rat brain by an
electrochemical in vivo flow-injection system with an on-line
microdialysis sampling. Anal Sci 19:61–65
11. Monge-Acuña AA, Fornaguera-Trias J (2009) A high perfor-
mance liquid chromatography method with electrochemical
detection of gamma-aminobutyric acid, glutamate and glutamine
in rat brain homogenates. J Neurosci Methods 183:176–181
12. Huang T, Yang L, Gitzen J, Kissinger PT, Vreeke M, Heller A
(1995) Detection of basal acetylcholine in rat brain micro-
dialysate. J Chromatogr B Biomed Appl 670:323–327
13. Shackman HM, Shou M, Cellar NA, Watson CJ, Kennedy RT
(2007) Microdialysis coupled on-line to capillary liquid chroma-
tography with tandem mass spectrometry for monitoring acetyl-
choline in vivo. J Neurosci Methods 159:86–92
14. Prokai L, Fry ák P, Stevens SM, Nguyen V (2008) Measurement
of acetylcholine in rat brain microdialysates by LC–isotope
dilution tandem MS. Chromatographia 68:101–105
15. Zhu Y, Wong PSH, Cregor M, Gitzen JF, Coury LA, Kissinger PT
(2000) In vivo microdialysis and reverse phase ion pair liquid
chromatography/tandem mass spectrometry for the determination
and identification of acetylcholine and related compounds in rat
brain. Rapid Commun Mass Spectrom 14:1695–1700
16. van Dam J, Eman M, Frank J, Lange H, van Dedem G, Heijnen S
(2002) Analysis of glycolytic intermediates in Saccharomyces
cerevisiae using anion exchange chromatography and electrospray
ionization with tandem mass spectrometric detection. Anal Chim
Acta 460:209–218
17. Uran S, Landmark KE, Hjellum G, Skotland T (2007) Quantifi-
cation of 13C pyruvate and 13C lactate in dog blood by reversed-
phase liquid chromatography-electrospray ionization mass spec-
trometry after derivatization with 3-nitrophenylhydrazine. J Pharm
Biomed Anal 44:947–954
18. Eckstein JA, Ammerman GM, Reveles JM, Ackermann BL
(2008) Analysis of glutamine, glutamate, pyroglutamate, and
GABA in cerebrospinal fluid using ion pairing HPLC with
positive electrospray LC/MS/MS. J Neurosci Methods 171:190–
196
19. Alpert AJ (1990) Hydrophilic-interaction chromatography for the
separation of peptides, nucleic acids and other polar compounds. J
Chromatogr 499:177–196
20. Zhang X, Rauch A, Xiao H, Rainer G, Logothetis NK (2008)
Mass spectrometry-based neurochemical analysis: perspectives for
primate research. Expert Rev Proteomics 5:641–652
21. Schlichtherle-Cerny H, Affolter M, Cerny C (2003) Hydrophilic
interaction liquid chromatography coupled to electrospray mass
spectrometry of small polar compounds in food analysis. Anal
Chem 75:2349–2354
22. Fu B, Gao X, Zhang SP, Cai Z, Shen J (2008) Quantification of
acetylcholine in microdialysate of subcutaneous tissue by hydro-
philic interaction chromatography/tandem mass spectrometry.
Rapid Commun Mass Spectrom 22:1497–1502
23. Zhang X, Rauch A, Lee H, Xiao H, Rainer G, Logothetis NK
(2007) Capillary hydrophilic interaction chromatography/mass
spectrometry for simultaneous determination of multiple neuro-
transmitters in primate cerebral cortex. Rapid Commun Mass
Spectrom 21:3621–3628
24. Preinerstorfer B, Schiesel S, Lämmerhofer M, Lindner W (2009)
Metabolic profiling of intracellular metabolites in fermentation
broths from [beta]-lactam antibiotics production by liquid
chromatography-tandem mass spectrometry methods. J Chroma-
togr A 1217:312–328
25. Uutela P, Reinila R, Piepponen P, Ketola RA, Kostiainen R (2005)
Analysis of acetylcholine and choline in microdialysis samples by
liquid chromatography/tandem mass spectrometry. Rapid Com-
mun Mass Spectrom 19:2950–2956
26. Kaddurah-Daouk R, Krishnan KR (2009) Metabolomics: a global
biochemical approach to the study of central nervous system
diseases. Neuropsychopharmacology 34:173–186
27. Viklund C, Ponten E, Glad B, Irgum K, Horstedt P, Svec F (1997)
“Molded” Macroporous Poly(glycidyl methacrylate-co-
trimethylolpropane trimethacrylate) Materials with Fine Con-
trolled Porous Properties: Preparation of Monoliths Using Photo-
initiated Polymerization. Chem Mater 463–471
28. Cech NB, Enke CG (2001) Practical implications of some recent
studies in electrospray ionization fundamentals. Mass Spectrom
Rev 20:362–387
29. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi
A, Layloff T, Viswanathan CT, Cook CE, McDowall RD et al
(1991) Analytical methods validation: bioavailability, bioequiva-
lence and pharmacokinetic studies Conference report. Eur J Drug
Metab Pharmacokinet 16:249–255
30. Food and Drug Administration (2001) Guidance for industry:
bioanalytical method validation. US Department of Health and
Human Services, FDA, Center for Drug Evaluation and Research.
http://www.fda.gov/cder/guidance/index.htm.
31. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003)
Strategies for the assessment of matrix effect in quantitative
bioanalytical methods based on HPLC-MS/MS. Anal Chem
75:3019–3030
32. Molina JA, Gomez P, Vargas C, Ortiz S, Perez-Rial S, Uriguen L,
Oliva JM, Villanueva C, Manzanares J (2005) Neurotransmitter
amino acid in cerebrospinal fluid of patients with dementia with
Lewy bodies. J Neural Transm 112:557–563
33. Hawkins RA (2009) The blood–brain barrier and glutamate. Am J
Clin Nutr 90:867S–874S
34. Boutelle MG, Fellows LK, Cook C (1992) Enzyme packed bed
system for the on-line measurement of glucose, glutamate, and
lactate in brain microdialysate. Anal Chem 64:1790–1794
35. Bjerring PN, Hauerberg J, Frederiksen HJ, Jorgensen L, Hansen
BA, Tofteng F, Larsen FS (2008) Cerebral glutamine concentra-
tion and lactate-pyruvate ratio in patients with acute liver failure.
Neurocrit Care 9:3–7
36. Mintun MA, Vlassenko AG, Rundle MM, Raichle ME (2004)
Increased lactate/pyruvate ratio augments blood flow in physio-
logically activated human brain. Proc Natl Acad Sci USA
101:659–664
37. Kawashima K, Oohata H, Fujimoto K, Suzuki T (1987) Plasma
concentration of acetylcholine in young women. Neurosci Lett
80:339–342
38. Fujii T, Yamada S, Yamaguchi N, Fujimoto K, Suzuki T,
Kawashima K (1995) Species differences in the concentration of
acetylcholine, a neurotransmitter, in whole blood and plasma.
Neurosci Lett 201:207–210
39. Cynober LA (2002) Plasma amino acid levels with a note on
membrane transport: characteristics, regulation, and metabolic
significance. Nutrition 18:761–766
40. Bellander BM, Cantais E, Enblad P, Hutchinson P, Nordström CH,
Robertson C, Sahuquillo J, Smith M, Stocchetti N, Ungerstedt U
(2004) Consensus meeting on microdialysis in neurointensive
care. Intensive Care Med 30:2166–2169
41. Iadecola C (2004) Neurovascular regulation in the normal brain
and in Alzheimer’s disease. Nat Rev Neurosci 5:347–360

ht
tp
://
do
c.
re
ro
.c
h
42. Samuelsson C, Hillered L, Zetterling M, Enblad P, Hesselager G,
Ryttlefors M, Kumlien E, Lewen A, Marklund N, Nilsson P, Salci
K, Ronne-Engstrom E (2007) Cerebral glutamine and glutamate
levels in relation to compromised energy metabolism: a micro-
dialysis study in subarachnoid hemorrhage patients. J Cereb
Blood Flow Metab 27:1309–1317
43. Richards DA, Tolias CM, Sgouros S, Bowery NG (2003)
Extracellular glutamine to glutamate ratio may predict outcome
in the injured brain: a clinical microdialysis study in children.
Pharmacol Res 48:101–109
44. Raman L, Tkac I, Ennis K, Georgieff MK, Gruetter R, Rao R (2005)
In vivo effect of chronic hypoxia on the neurochemical profile of the
developing rat hippocampus. Brain Res Dev Brain Res 156:202–209
45. Petroff OA, Errante LD, Rothman DL, Kim JH, Spencer DD
(2002) Glutamate-glutamine cycling in the epileptic human
hippocampus. Epilepsia 43:703–710

ht
tp
://
do
c.
re
ro
.c
h
